Hepatitis C virus seroprevalence in the developmentally disabled. 1992

W M Levinson, and G P Wormser, and G Forseter, and M Calmann, and T A O'Brien
Department of Pediatrics, New York Medical College, Valhalla.

BACKGROUND Hepatitis C virus (HCV) is the principal cause of nonenteric non-A, non-B hepatitis worldwide. While it has been well documented that people with developmental disabilities are at an increased risk for infections with hepatitis B virus, little is known of the prevalence of HCV infection among this population. METHODS Serum samples obtained from 113 evaluable outpatients with developmental disabilities at one center in suburban New York City (NY) were tested for antibodies to HCV and hepatitis B core antibody. RESULTS None of the 113 samples tested positive for HCV antibody by enzyme-linked immunosorbent assay, whereas 24 (21%) showed serologic evidence of past hepatitis B virus infection on the basis of hepatitis B core antibody positivity. Three (2.7%) were also positive for hepatitis B surface antigen. CONCLUSIONS In contrast to hepatitis B virus, HCV infection is uncommon among outpatients with developmental disabilities in suburban New York City. Further testing for HCV is indicated to determine if these results can be generalized to individuals within institutions, or to individuals in other geographic locations.

UI MeSH Term Description Entries
D008297 Male Males
D008607 Intellectual Disability Subnormal intellectual functioning which originates during the developmental period. This has multiple potential etiologies, including genetic defects and perinatal insults. Intelligence quotient (IQ) scores are commonly used to determine whether an individual has an intellectual disability. IQ scores between 70 and 79 are in the borderline range. Scores below 67 are in the disabled range. (from Joynt, Clinical Neurology, 1992, Ch55, p28) Disability, Intellectual,Idiocy,Mental Retardation,Retardation, Mental,Deficiency, Mental,Intellectual Development Disorder,Mental Deficiency,Mental Retardation, Psychosocial,Deficiencies, Mental,Development Disorder, Intellectual,Development Disorders, Intellectual,Disabilities, Intellectual,Disorder, Intellectual Development,Disorders, Intellectual Development,Intellectual Development Disorders,Intellectual Disabilities,Mental Deficiencies,Mental Retardations, Psychosocial,Psychosocial Mental Retardation,Psychosocial Mental Retardations,Retardation, Psychosocial Mental,Retardations, Psychosocial Mental
D009519 New York City City located at the mouth of the Hudson River, in New York State.
D005260 Female Females
D006508 Hepatitis Antibodies Immunoglobulins raised by any form of viral hepatitis; some of these antibodies are used to diagnose the specific kind of hepatitis. Antibodies, Hepatitis
D006510 Hepatitis B Antibodies Antibodies to the HEPATITIS B ANTIGENS, including antibodies to the surface (Australia) and core of the Dane particle and those to the "e" antigens. Anti-Australia Antigens,Anti-HBAg,Anti-Hepatitis B Antigens,Anti HBAg,Hepatitis B Virus Antibodies,Anti Australia Antigens,Anti Hepatitis B Antigens,Antibodies, Hepatitis B,Antigens, Anti-Australia,Antigens, Anti-Hepatitis B,B Antibodies, Hepatitis,B Antigens, Anti-Hepatitis,HBAg, Anti
D006512 Hepatitis B Core Antigens The hepatitis B antigen within the core of the Dane particle, the infectious hepatitis virion. HBcAg,Hepatitis B Core Antigen
D006526 Hepatitis C INFLAMMATION of the LIVER in humans caused by HEPATITIS C VIRUS, a single-stranded RNA virus. Its incubation period is 30-90 days. Hepatitis C is transmitted primarily by contaminated blood parenterally and is often associated with transfusion and intravenous drug abuse. However, in a significant number of cases, the source of hepatitis C infection is unknown. Hepatitis, Viral, Non-A, Non-B, Parenterally-Transmitted,Parenterally-Transmitted Non-A, Non-B Hepatitis,PT-NANBH,Parenterally Transmitted Non A, Non B Hepatitis
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults

Related Publications

W M Levinson, and G P Wormser, and G Forseter, and M Calmann, and T A O'Brien
December 2012, European journal of public health,
W M Levinson, and G P Wormser, and G Forseter, and M Calmann, and T A O'Brien
February 1999, Epidemiology and infection,
W M Levinson, and G P Wormser, and G Forseter, and M Calmann, and T A O'Brien
February 2002, Enfermedades infecciosas y microbiologia clinica,
W M Levinson, and G P Wormser, and G Forseter, and M Calmann, and T A O'Brien
July 2003, Saudi medical journal,
W M Levinson, and G P Wormser, and G Forseter, and M Calmann, and T A O'Brien
November 1996, Releve epidemiologique hebdomadaire,
W M Levinson, and G P Wormser, and G Forseter, and M Calmann, and T A O'Brien
January 2007, Gastroenterologie clinique et biologique,
W M Levinson, and G P Wormser, and G Forseter, and M Calmann, and T A O'Brien
January 2018, The Brazilian journal of infectious diseases : an official publication of the Brazilian Society of Infectious Diseases,
W M Levinson, and G P Wormser, and G Forseter, and M Calmann, and T A O'Brien
January 1996, Dakar medical,
W M Levinson, and G P Wormser, and G Forseter, and M Calmann, and T A O'Brien
January 2002, Human antibodies,
W M Levinson, and G P Wormser, and G Forseter, and M Calmann, and T A O'Brien
January 1993, Schweizerische medizinische Wochenschrift,
Copied contents to your clipboard!